Comparing new treatments for idiopathic pulmonary fibrosis – a network meta-analysis

The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation

(2015) Emma Loveman et al.   HEALTH TECHNOLOGY ASSESSMENT

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

A New Hope for Idiopathic Pulmonary Fibrosis

(2014) Gary M. Hunninghake   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Demystifying trial networks and network meta-analysis

(2013) E. J. Mills et al.   BMJ-British Medical Journal

Evidence Synthesis for Decision Making 2

(2012) Sofia Dias et al.   MEDICAL DECISION MAKING

Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis

(2012) SAKAE HOMMA et al.   RESPIROLOGY

Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium

(2011) Steven D. Nathan et al.   CHEST

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

(2011) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pirfenidone in idiopathic pulmonary fibrosis

(2009) H. Taniguchi et al.   EUROPEAN RESPIRATORY JOURNAL

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

(2009) Georgia Salanti et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY